American kids are no longer routinely being recommended shots against hepatitis A, meningitis, rotavirus and the flu.

It is 20 years since we began managing money in Australia, and this quarter’s excellent performance has been a welcome ...

Lucknow: CM Yogi Adityanath on Monday said infrastructure development is essential for development, but it cannot be at the ...

The Defence Acquisition Council, chaired by Defence Minister, Rajnath Singh, approved the Acceptance of Necessity (AON) — an ...

Cyber attacks in 2025 grew more sophisticated and coordinated, with generative AI enabling large-scale, stealthy operations ...

Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...

CSL shares have dropped significantly in 2025, reaching a seven-year low, due to restructuring and downgraded growth prospects. The company’s core business is robust, with ongoing global demand and ...

CSL shares have seen a significant downturn due to recent challenges, yet analysts see potential for recovery, with a projected rebound to $275, driven by its strong foundation and global healthcare ...

Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that, based on preliminary and unaudited financial data, the Company expects total U.S. net product sales for the fourth quarter of 2025 to be ...